eNauka - pregled

Pregled prema Autor Kandolf-Sekulovic, Lidija O

Prikaz rezultata 1 do 20 od 30  sledeće >
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2010A hundred years of dermatovenerology in the Serbian ArmyDinic, Miroslav Z; Kandolf-Sekulovic, Lidija O; Zecevic, Rados DNaučni članak
23M23 - Rad u međ. časopisu
2019Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countriesWilking, Nils; Bucsics, Anna; Kandolf-Sekulovic, Lidija O; Kobelt, Gisela; Laslop, Andrea; Makaroff, Lydia; Roediger, Alexander; Zielinski, ChristophNaučni članak
21M21 - Rad u vrhunskom međ. časopisu
2009Choice of appropriate antidepressant agent in patient with impaired liver function: Case reportVukovic, Jelena M; Dragojevic-Simic, Viktorija M; Jandric, Dusan; Kovacevic, Aleksandra M  ; Kandolf-Sekulovic, Lidija O; Bucan, Vesna MKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2013Churg-Strauss syndrome: A case reportDinic, Miroslav Z; Kandolf-Sekulovic, Lidija O; Zolotarevski, Lidija D; Zecevic, Rados DNaučni članak
23M23 - Rad u međ. časopisu
2023Cutaneous manifestations induced by check point inhibitors in 120 melanoma patients-The European MelSkinTox studyL'Orphelin, J-M; ...; Kandolf-Sekulovic, Lidija O; ...; Dujovic, B; ...; (broj, koautora 22)Naučni članak
21aM21a - Rad u međ. časopisu izuzetnih vrednosti
2019Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC)Lebbe, Celeste; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 23)Naučni članak
21M21 - Rad u vrhunskom međ. časopisu
2019Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 CentersDessinioti, Clio; ...; Kandolf-Sekulovic, Lidija O; Radevic, Tatjana; ...; (broj, koautora 41)Naučni članak
21aM21a - Rad u međ. časopisu izuzetnih vrednosti
2022Efficacy and safety of sequencing with vemurafenib (V) plus cobimetinib (C) followed by atezolizumab (Atezo) in patients (pts) with advanced BRAF(V600)-positive melanoma: Interim analysis of the ImmunoCobiVem study. (✓)Schadendorf, Dirk; ...; Kandolf-Sekulovic, Lidija O; ...; Mijuskovic, Željko P  ; ...; (broj, koautora 20)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2022EMRseq: Registry-based outcome analysis on 1,000 patients with BRAF V600-mutated metastatic melanoma in Europe treated with either immune checkpoint or BRAF-/MEK inhibition.Weichenthal, Michael; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 20)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2023European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023Stratigos, Alexander J; ...; Hauschild, Axel; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 40)Naučni članak
21M21 - Rad u vrhunskom međ. časopisu
2020European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and preventionStratigos, Alexander J; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 28)Naučni članak
21M21 - Rad u vrhunskom međ. časopisu
2020European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. TreatmentStratigos, Alexander J; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 28)Naučni članak
21M21 - Rad u vrhunskom međ. časopisu
2013Fulminant Wegener's granulomatosis: A case reportDinic, Miroslav Z; Kandolf-Sekulovic, Lidija O; Zolotarevski, Lidija D; Zecevic, Rados DNaučni članak
23M23 - Rad u međ. časopisu
2003Immunomodulatory effects of low-intensity near-infrared laser irradiation on contact hypersensitivity reactionKandolf-Sekulovic, Lidija O; Kataranovski, Milena V ; Pavlovic, Milos DNaučni članak
22M22 - Rad u istaknutom međ. časopisu
2015Lymphoscintigraphy and Sentinel Lymph Node Biopsy in Cutaneous Melanoma: Analysis of 201 Patients From a Single InstitutionJaukovic, Ljiljana Dj; Rajovic, Milica I; Radulovic, Marija; Kandolf-Sekulovic, Lidija OKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2018Major determinants of delayed access to innovative medicines for metastatic melanoma: The results of Melanoma World Society and European Association of Dermato-Oncology surveyKandolf-Sekulovic, Lidija O; ...; (broj, koautora 20)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2019MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohortPellegrini, Cristina; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 190)Naučni članak
21aM21a - Rad u međ. časopisu izuzetnih vrednosti
2016More than 5000 patients with metastatic melanoma in Europe per year do not have access to new life-saving drugsKandolf-Sekulovic, Lidija O; ...; (broj, koautora 20)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2022Outcome of PD-1 inhibitor therapy of advanced melanoma patients according to demographic factors in a real-world setting across EuropeWeichenthal, Michael; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 20)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2022Polymorphisms in toll-like receptor 3 and 4 genes as prognostic and outcome biomarkers in melanoma patientsOstojic, Nikola G; Radevic, Tatjana; Kandolf-Sekulovic, Lidija O; Djordjevic, Boban  ; Jaukovic, Ljiljana Dj; Stepic, Nenad V; Supic, Gordana M  Naučni članak
22M22 - Rad u istaknutom međ. časopisu